T. Komori et al., BIGUANIDES MAY PRODUCE HYPOGLYCEMIC ACTION IN ISOLATED RAT HEPATOCYTES THROUGH THEIR EFFECTS ON L-ALANINE TRANSPORT, Diabetes research and clinical practice, 22(1), 1993, pp. 11-17
We investigated the mechanisms of the effects of the biguanides metfor
min and buformin on hepatic gluconeogenesis in hepatocytes isolated fr
om normal rats. Both 10 nM glucagon and 50 muM dibutyryl cAMP increase
d [H-3]alanine uptake in isolated hepatocytes of normal rats by about
150% and 55%, respectively, compared with the effect of 5 mM alanine a
lone. Metformin (3 mM) reduced glucagon-stimulated [H-3]alanine uptake
to the level seen with alanine alone; buformin (3 mM) inhibited gluca
gon-stimulated [H-3]alanine uptake by about 69%. The effects of biguan
ides on dibutyryl cAMP-stimulated [H-3]alanine uptake were similar, bu
t of smaller magnitude compared with those observed in the presence of
glucagon. Ouabain (3 mM) had a stonger inhibitory effect on [H-3]alan
ine uptake than the biguanides. However, 3 mM tolbutamide failed to su
ppress [H-3]alanine uptake in the presence or absence of glucagon or d
ibutyryl cAMP. Our results suggest that the inhibition of alanine upta
ke, related to a reduction in the Na+/L-alanine transport system, is a
possible mechanism of biguanide-related inhibition of hepatic glucone
ogenesis.